Openly accessible

Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial

Fowler, Robert A., Mittmann, Nicole, Geerts, William H., Heels-Ansdell, Diane, Gould, Michael K., Guyatt, Gordon, Krahn, Murray, Finfer, Simon, Pinto, Ruxandra, Chan, Brian, Ormanidhi, Orges, Arabi, Yaseen, Qushmaq, Ismael, Rocha, Marcelo G., Dodek, Peter, McIntyre, Lauralyn, Hall, Richard, Ferguson, Niall D., Mehta, Sangeeta, Marshall, John C., Doig, Christopher James, Muscedere, John, Jacka, Michael J., Klinger, James R., Vlahakis, Nicholas, Orford, Neil, Seppelt, Ian, Skrobik, Yoanna K., Sud, Sachin, Cade, John F., Cooper, Jamie, Cook, Deborah, Canadian Critical Care Trials Group and Australia and New Zealand Intensive Care Society Clinical Trials Group 2014, Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial, Trials, vol. 15, pp. 1-11, doi: 10.1186/1745-6215-15-502.

Attached Files
Name Description MIMEType Size Downloads
orford-economicevaluation-2014.pdf Published version application/pdf 608.02KB 2

Title Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial
Author(s) Fowler, Robert A.
Mittmann, Nicole
Geerts, William H.
Heels-Ansdell, Diane
Gould, Michael K.
Guyatt, Gordon
Krahn, Murray
Finfer, Simon
Pinto, Ruxandra
Chan, Brian
Ormanidhi, Orges
Arabi, Yaseen
Qushmaq, Ismael
Rocha, Marcelo G.
Dodek, Peter
McIntyre, Lauralyn
Hall, Richard
Ferguson, Niall D.
Mehta, Sangeeta
Marshall, John C.
Doig, Christopher James
Muscedere, John
Jacka, Michael J.
Klinger, James R.
Vlahakis, Nicholas
Orford, Neil
Seppelt, Ian
Skrobik, Yoanna K.
Sud, Sachin
Cade, John F.
Cooper, Jamie
Cook, Deborah
Canadian Critical Care Trials Group
Australia and New Zealand Intensive Care Society Clinical Trials Group
Journal name Trials
Volume number 15
Article ID 502
Start page 1
End page 11
Total pages 11
Publisher BMC
Place of publication London, Eng.
Publication date 2014-12-20
ISSN 1745-6215
Keyword(s) Anticoagulants
Australia
Brazil
Clinical Protocols
Cost Savings
Cost-Benefit Analysis
Critical Care
Dalteparin
Drug Costs
Fibrinolytic Agents
Heparin
Hospital Costs
Humans
Models, Economic
North America
Prospective Studies
Quality-Adjusted Life Years
Research Design
Saudi Arabia
Time Factors
Treatment Outcome
Venous Thromboembolism
Canadian Critical Care Trials Group
Australia and New Zealand Intensive Care Society Clinical Trials Group
Language eng
DOI 10.1186/1745-6215-15-502
Field of Research 1102 Cardiovascular Medicine And Haematology
1103 Clinical Sciences
HERDC Research category C1 Refereed article in a scholarly journal
Copyright notice ©2014, The Authors
Free to Read? Yes
Use Rights Creative Commons Attribution licence
Persistent URL http://hdl.handle.net/10536/DRO/DU:30113376

Document type: Journal Article
Collections: School of Medicine
Open Access Collection
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in TR Web of Science
Scopus Citation Count Cited 2 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 7 Abstract Views, 3 File Downloads  -  Detailed Statistics
Created: Mon, 10 Sep 2018, 14:26:50 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.